CRISPR-Cas Systems

CRISPR Fundamentals - Genome's Guardian

• CRISPR: Clustered Regularly Interspaced Short Palindromic Repeats.
• Natural Role: Adaptive immunity in bacteria/archaea against phages & plasmids.
• Key Locus Elements:
  • Repeats: Short, palindromic DNA sequences.
  • Spacers: Unique sequences derived from foreign DNA, interspersing repeats.
  • Cas Genes: CRISPR-associated genes encoding proteins (e.g., nucleases).
  • Leader Sequence: AT-rich region, directs CRISPR array transcription.

⭐ Spacers in the CRISPR array are derived from foreign DNA, acting as a molecular memory of past infections.

Mechanism of Action - DNA Scissors Dance

📌 AEI: Three stages:

• 1. Adaptation (Spacer Acquisition): Foreign DNA (protospacers) integrated as new spacers into CRISPR array.
• 2. Expression (crRNA Biogenesis): CRISPR array transcribed to pre-crRNA, processed to mature crRNAs. tracrRNA binds crRNA, forming a complex with Cas9 protein (or engineered as sgRNA with Cas9).

  ⭐ The PAM (Protospacer Adjacent Motif) is crucial for target DNA cleavage by Cas9. It's downstream of the target; its absence in the host CRISPR locus prevents self-targeting.

• 3. Interference (Target Cleavage): crRNA (within sgRNA for Cas9) guides Cas nuclease to complementary target DNA via base pairing. PAM sequence (e.g., $5'-NGG-3'$ for S. pyogenes Cas9) on target DNA is vital for Cas binding & cleavage (typically a Double-Strand Break/DSB by Cas9).

CRISPR System Types - The Cas Clan

• Class 1: Multi-subunit effector complexes.
• Class 2: Single effector protein (key for gene editing).
  • Type II (Cas9): Targets DNA, causes Double-Strand Breaks (DSBs).
  • Type V (Cas12a/Cpf1): DNA target, TTN PAM, staggered cuts, self-processes crRNA.
  • Type VI (Cas13): Targets RNA.

Comparison: Cas9 vs. Cas12a

Applications & Innovations - Gene Editing & Beyond

• Genome Editing:
  • Gene knockout (NHEJ); Gene insertion/correction (HDR + donor template).
• Transcriptional Regulation: dCas9 (catalytically dead) with activators/repressors.
• Advanced Precision Editing:
  • Base Editing: Deaminase-Cas9 fusion for point mutations (e.g., $C \rightarrow T$).
  • Prime Editing: Versatile edits without extensive DSBs or donor DNA.
• Diagnostics:
  • SHERLOCK (Cas13): Ultrasensitive RNA detection.
  • DETECTR (Cas12): Rapid DNA detection.
• Therapeutics: Sickle cell disease, β-thalassemia, CAR-T cell therapy enhancement.

⭐ Base editors allow for precise single-nucleotide changes in DNA without requiring double-strand breaks, reducing the risk of indels associated with NHEJ.

oka

Limitations & Ethics - Hurdles & Headaches

• Technical Hurdles:
  • Off-target effects: mutations at unintended sites.
  • On-target large deletions/rearrangements.
  • Mosaicism: mixed cell populations post-editing.
  • Delivery challenges: efficient in vivo methods (viral, non-viral).
  • Immunogenicity of Cas proteins.
• Ethical Headaches:
  • Germline editing: heritable changes.
  • Enhancement vs. therapy debate.
  • Accessibility and equity.
  • Informed consent complexities.

⭐ Off-target cleavage by Cas nucleases is a major safety concern for therapeutic applications, requiring careful guide RNA design and validation methods.

High‑Yield Points - ⚡ Biggest Takeaways

• CRISPR-Cas9: A prokaryotic adaptive immune system against phages/plasmids.
• Components: CRISPR arrays (repeats/spacers) & Cas proteins (e.g., Cas9 nuclease).
• Guide RNA (gRNA) directs Cas9 to complementary target DNA sequences.
• Cas9 induces double-strand breaks (DSBs) at the target, enabling gene editing.
• Applications: Gene knockout, knock-in, gene regulation, and diagnostics.
• PAM (Protospacer Adjacent Motif) sequence is vital for Cas9 target recognition and cleavage.
• Revolutionizing gene therapy, disease modeling, and antimicrobial research.